Strategy for large-scale isolation of enantiomers in drug discovery.

Drug Discov Today

Respiratory, Inflammation and Autoimmunity, Innovative Medicines, AstraZeneca R&D, Gothenburg 431 83, Sweden.

Published: January 2017

A strategy for large-scale chiral resolution is illustrated by the isolation of pure enantiomer from a 5kg batch. Results from supercritical fluid chromatography will be presented and compared with normal phase liquid chromatography. Solubility of the compound in the supercritical mobile phase was shown to be the limiting factor. To circumvent this, extraction injection was used but shown not to be efficient for this compound. Finally, a method for chiral resolution by crystallization was developed and applied to give diastereomeric salt with an enantiomeric excess of 99% at a 91% yield. Direct access to a diverse separation tool box will be shown to be essential for solving separation problems in the most cost and time efficient way.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2016.09.018DOI Listing

Publication Analysis

Top Keywords

strategy large-scale
8
chiral resolution
8
large-scale isolation
4
isolation enantiomers
4
enantiomers drug
4
drug discovery
4
discovery strategy
4
large-scale chiral
4
resolution illustrated
4
illustrated isolation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!